5-hydroxytryptophan has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, HS; Wang, RY | 1 |
| Huang, X; Kanthasamy, A; Nichols, DE; Sprague, JE | 1 |
| Gudelsky, GA; Nash, JF | 1 |
| Baumann, MH; Dersch, CM; Rothman, RB; Wang, X | 1 |
| Ashford, KA; Christie, IN; Evans, AK; Lowry, CA; Reinders, N; Wakerley, JB | 1 |
| Abraham, B; Aronsen, D; Colussi-Mas, J; Do, J; Schenk, S | 1 |
6 other study(ies) available for 5-hydroxytryptophan and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
The action of (+/-)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system.
Topics: 3,4-Methylenedioxyamphetamine; 5-Hydroxytryptophan; alpha-Methyltyrosine; Analysis of Variance; Animals; Cerebral Cortex; Designer Drugs; Dopamine; Electrophysiology; Fenclonine; Levodopa; Male; Methyltyrosines; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Rats; Rats, Inbred Strains; Reference Values; Serotonin | 1991 |
Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Brain Diseases; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Rats; Rats, Sprague-Dawley; Serotonin; Tryptophan | 1994 |
Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Carrier Proteins; Corpus Striatum; Dopamine; Drug Synergism; Fluoxetine; Frontal Lobe; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tetrodotoxin | 1996 |
Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents, Second-Generation; Binding, Competitive; Brain; Brain Chemistry; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Hallucinogens; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Presynaptic Terminals; Radioligand Assay; Rats; Rats, Sprague-Dawley; Recovery of Function; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptic Transmission | 2007 |
Evidence for serotonin synthesis-dependent regulation of in vitro neuronal firing rates in the midbrain raphe complex.
Topics: 5-Hydroxytryptophan; Animals; Dose-Response Relationship, Drug; Fluoxetine; Hydrazines; Hydroxyindoleacetic Acid; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Pargyline; Piperazines; Pyridines; Raphe Nuclei; Rats; Rats, Wistar; Serotonin; Time Factors; Tryptophan | 2008 |
Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to 8-OHDPAT.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoreceptors; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin Receptor Agonists; Tryptophan Hydroxylase | 2013 |